H J Manley

Summary

Affiliation: University of Missouri-Kansas City
Country: USA

Publications

  1. ncbi request reprint Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients
    H J Manley
    School of Pharmacy, University of Missouri Kansas City, USA
    Perit Dial Int 20:686-93. 2000
  2. ncbi request reprint Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider
    Harold J Manley
    University of Missouri, Kansas City, Kansas City School of Pharmacy, Kansas City, MI 64108, USA
    Nephrol Dial Transplant 19:1842-8. 2004
  3. pmc Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study
    Harold J Manley
    School of Pharmacy, University of Missouri Kansas City, Kansas City, Missouri, USA
    BMC Nephrol 5:1. 2004
  4. pmc Medication-related problem type and appearance rate in ambulatory hemodialysis patients
    Harold J Manley
    University of Missouri Kansas City School of Pharmacy, Kansas City, MO, USA
    BMC Nephrol 4:10. 2003
  5. ncbi request reprint Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin
    Harold J Manley
    School of Pharmacy, University of Missouri Kansas City, Kansas City, Missouri 64108, USA
    Perit Dial Int 23:469-74. 2003
  6. ncbi request reprint Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis
    Harold J Manley
    School of Pharmacy, University of Missouri Kansas City, Kansas City, Missouri, USA
    Pharmacotherapy 23:861-5. 2003
  7. ncbi request reprint Gentamicin pharmacokinetics during slow daily home hemodialysis
    Harold J Manley
    University of Missouri Kansas City, Kansas City 64108, USA
    Kidney Int 63:1072-8. 2003
  8. ncbi request reprint Factors associated with medication-related problems in ambulatory hemodialysis patients
    Harold J Manley
    University of Missouri Kansas City, School of Pharmacy Dialysis Clinic, Inc MO, USA
    Am J Kidney Dis 41:386-93. 2003
  9. ncbi request reprint Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients
    H J Manley
    School of Pharmacy, University of Missouri Kansas City, USA
    Perit Dial Int 21:378-85. 2001
  10. ncbi request reprint Treatment of peritonitis in APD: pharmacokinetic principles
    Harold J Manley
    University of Missouri Kansas City, School of Pharmacy, Kansas City, Missouri 64108, USA
    Semin Dial 15:418-21. 2002

Detail Information

Publications27

  1. ncbi request reprint Intermittent intravenous piperacillin pharmacokinetics in automated peritoneal dialysis patients
    H J Manley
    School of Pharmacy, University of Missouri Kansas City, USA
    Perit Dial Int 20:686-93. 2000
    ..Use of intermittent antibiotic dosing is increasing in the treatment of peritoneal dialysis (PD)-related peritonitis. We studied the pharmacokinetics of intravenous (i.v.) piperacillin in automated PD patients...
  2. ncbi request reprint Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider
    Harold J Manley
    University of Missouri, Kansas City, Kansas City School of Pharmacy, Kansas City, MI 64108, USA
    Nephrol Dial Transplant 19:1842-8. 2004
    ..The objective was to analyse and compare haemodialysis (HD) patient medication prescribing patterns between the Dialysis Clinic, Inc. (DCI) database and the USRDS report...
  3. pmc Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study
    Harold J Manley
    School of Pharmacy, University of Missouri Kansas City, Kansas City, Missouri, USA
    BMC Nephrol 5:1. 2004
    ..HD patients may be prescribed high-flux (HF) or high-efficiency (HE) dialysis membranes. The extent of iron sucrose and iron dextran removal by HD using HF or HE membranes and by ultrafiltration rate (UFR) is unknown...
  4. pmc Medication-related problem type and appearance rate in ambulatory hemodialysis patients
    Harold J Manley
    University of Missouri Kansas City School of Pharmacy, Kansas City, MO, USA
    BMC Nephrol 4:10. 2003
    ..Hemodialysis (HD) patients are at risk for medication-related problems (MRP). The MRP number, type, and appearance rate over time in ambulatory HD patients has not been investigated...
  5. ncbi request reprint Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin
    Harold J Manley
    School of Pharmacy, University of Missouri Kansas City, Kansas City, Missouri 64108, USA
    Perit Dial Int 23:469-74. 2003
    ..To determine the impact of dialysate flow rate (DFR) on cefazolin pharmacokinetics (PK) in peritoneal dialysis (PD) patients...
  6. ncbi request reprint Thiazolidinedione safety and efficacy in ambulatory patients receiving hemodialysis
    Harold J Manley
    School of Pharmacy, University of Missouri Kansas City, Kansas City, Missouri, USA
    Pharmacotherapy 23:861-5. 2003
    ....
  7. ncbi request reprint Gentamicin pharmacokinetics during slow daily home hemodialysis
    Harold J Manley
    University of Missouri Kansas City, Kansas City 64108, USA
    Kidney Int 63:1072-8. 2003
    ..Slow daily home (SDH) hemodialysis (7 to 9 hours a day/6 days a week) use is increasing due to benefits observed with increased hemodialysis. We determined gentamicin pharmacokinetics for SDH hemodialysis patients...
  8. ncbi request reprint Factors associated with medication-related problems in ambulatory hemodialysis patients
    Harold J Manley
    University of Missouri Kansas City, School of Pharmacy Dialysis Clinic, Inc MO, USA
    Am J Kidney Dis 41:386-93. 2003
    ..Hemodialysis (HD) patients are at risk for medication-related problems. Patient characteristics associated with the number of medication-related problems in HD patients have not been investigated...
  9. ncbi request reprint Intravenous vancomycin pharmacokinetics in automated peritoneal dialysis patients
    H J Manley
    School of Pharmacy, University of Missouri Kansas City, USA
    Perit Dial Int 21:378-85. 2001
    ..p. thereafter (i.e., once daily) in APD patients...
  10. ncbi request reprint Treatment of peritonitis in APD: pharmacokinetic principles
    Harold J Manley
    University of Missouri Kansas City, School of Pharmacy, Kansas City, Missouri 64108, USA
    Semin Dial 15:418-21. 2002
    ..Knowledge of antibiotic disposition in PD patients will assist clinicians in appropriate IP antibiotic dose selection and prevention of dose-related adverse effects...
  11. ncbi request reprint Linezolid stability in peritoneal dialysis solutions
    Harold J Manley
    University of Missouri Kansas City, USA
    Perit Dial Int 22:419-22. 2002
  12. ncbi request reprint The clinical and economic impact of pharmaceutical care in end-stage renal disease patients
    Harold J Manley
    School of Pharmacy, University of Missouri, Kansas City 64108, USA
    Semin Dial 15:45-9. 2002
    ..Economic analysis suggests that for every $1 spent on pharmaceutical care, the healthcare system saves an estimated $3.98. Provision of pharmaceutical care by pharmacists should be consdiered for all ESRD patients...
  13. ncbi request reprint Prediction and prevention of contrast nephropathy
    P A McCullough
    Cardiology Section, Department of Internal Medicine, University of Missouri Kansas City, Truman Medical Center, 2301 Holmes St, Kansas City, MO 64108, USA
    J Interv Cardiol 14:547-58. 2001
    ..As the population ages, breakthroughs with respect to new contrast agents or effective prevention measures will be needed to offer PCI to the spectrum of patients at risk for renal injury...
  14. ncbi request reprint Intraperitoneal cefazolin and ceftazidime effects on human peritoneal mesothelial cell release of cancer antigen-125
    Harold J Manley
    School of Pharmacy, University of Missouri, Kansas City, MO, USA
    Ann Pharmacother 38:2035-40. 2004
    ..Human peritoneal mesothelial cells (HPMCs) may be affected by high IP cefazolin and ceftazidime concentrations. Peritoneal dialysate cancer antigen-125 (CA-125) appearance rate can be used to measure HPMC damage...
  15. ncbi request reprint Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients
    Harold J Manley
    University of Missouri Kansas City School of Pharmacy, USA
    Nephrol News Issues 19:27-8, 33-4, 36-8. 2005
    ..Health care providers should be aware of the medication cost burden in HD patients. Efforts to decrease this burden, whether through pharmaceutical care, generic prescribing, or sampling programs, should be considered...
  16. ncbi request reprint Medication-related problems in ambulatory hemodialysis patients: a pooled analysis
    Harold J Manley
    Albany College of Pharmacy, Albany, NY 12208, USA
    Am J Kidney Dis 46:669-80. 2005
    ..We conducted a pooled analysis to gain additional insight into the frequency, type, and severity of medication-related problems and extrapolated the data to the entire US HD population...
  17. ncbi request reprint Vancomycin disposition following intraperitoneal administration in children receiving peritoneal dialysis
    Douglas L Blowey
    Department of Pediatric Nephrology, Children s Mercy Hospitals and Clinics, University of Missouri at Kansas City, Missouri, USA
    Perit Dial Int 27:79-85. 2007
    ..g., automated PD (APD)] and long-dwell [e.g., continuous ambulatory PD (CAPD)] PD...
  18. ncbi request reprint Treatment of hypertension and diabetes mellitus in patients with chronic kidney disease: a review
    Rafia S Rasu
    University of Missouri Kansas City, School of Pharmacy, 4247 Health Sciences Building, 2464 Charlotte Street, Kansas City, MO 64106, USA
    Expert Opin Pharmacother 8:2543-51. 2007
    ..Active involvement of all healthcare team members can reduce progression of CKD and improve quality of life outcomes in CKD patients...
  19. ncbi request reprint Comment: Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines
    Harold J Manley
    Ann Pharmacother 36:1975-6; author reply 1976. 2002
  20. ncbi request reprint Linezolid disposition during peritonitis: a case report
    Nicole M Allcock
    Department of Pharmacy Practice, University of Missouri Kansas City School of Pharmacy, USA
    Perit Dial Int 24:68-70. 2004
  21. ncbi request reprint Providing free medications to dialysis patients. A description of a multidisciplinary team medication sampling and patient assistance program
    Debra K Drayer
    Dialysis Clinic Inc, Kansas City, MO, USA
    Nephrol News Issues 18:25-9. 2004
  22. ncbi request reprint Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease
    Peter A McCullough
    Department of Basic Science, Cardiology Section, University of Missouri Kansas City, School of Medicine, Truman Medical Center, Kansas City, MO 64108, USA
    Am Heart J 144:226-32. 2002
    ....
  23. ncbi request reprint Drug record discrepancies in an outpatient electronic medical record: frequency, type, and potential impact on patient care at a hemodialysis center
    Harold J Manley
    Department of Pharmacy Practice, University of Missouri Kansas City, MO 64102, USA
    Pharmacotherapy 23:231-9. 2003
    ..Record discrepancies are a potential source of drug-related problems. We sought to determine the extent to which drug record discrepancies occur in a hemodialysis population...
  24. ncbi request reprint Hepatitis B vaccination: addressing a drug-related problem in hemodialysis outpatients with a collaborative initiative
    Rowland J Elwell
    Albany College of Pharmacy, Albany, NY, USA
    Nephrol Nurs J 30:310-3. 2003
    ..Since the vaccine is indicated for all HD patients, this presented a drug-related problem (DRP): indication without treatment. In response, nurses and pharmacists initiated a proactive HBV vaccination program...
  25. ncbi request reprint Undertreatment of anemia in patients with chronic kidney disease in the United States: analysis of national outpatient survey data
    Rafia S Rasu
    University of Missouri Kansas City, Kansas City, Missouri, USA
    Clin Ther 29:1524-34. 2007
    ..Understanding anemia treatment patterns in national outpatient settings may assist evidence-based policy making by identifying the variations in physician prescriptions for chronic kidney disease (CKD) and reasons for such variations...
  26. ncbi request reprint Disease progression and the application of evidence-based treatment guidelines diagnose it early: a case for screening and appropriate management
    Harold J Manley
    VillageHealth Disease Management, Glenmont, NY 12077, USA
    J Manag Care Pharm 13:S6-12. 2007
    ....
  27. doi request reprint Vancomycin use in patients requiring hemodialysis: a literature review
    Katie E Pallotta
    Albany College of Pharmacy, Albany, New York 12208, USA
    Semin Dial 21:63-70. 2008
    ..This review provides a summary of the several concerns that exist in the dosing of vancomycin in HD patients today, and provides a summary table of intradialytic dosing regimens...